tiprankstipranks
TipRanksTop Financial ExpertsInsidersDavid Bonita

David Bonita Insider Profile

11 Followers
David Bonita, Director at Loxo Oncology, holds 1.65M shares in Prelude Therapeutics (Ticker: PRLD), holds 773.75K shares in ImageneBio (Ticker: IMA), holds 20.82K shares in Acutus Medical (Ticker: AFIB). Most recently, David Bonita Bought ― shares of Prelude Therapeutics on Apr 23, 2026 for an estimated value of $12.50M.
See the Hottest Stocks Based on Insider Trading >
tipranks
David Bonita

David Bonita
Loxo Oncology (LOXO)
Director

Ranked #97,621 out of 107,049 Corporate Insiders

Profitable Transactions

43%
9 out of 21 Profitable Transactions

Average Return

-19.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$186M
92.87%
4.64%
2.50%
<0.01%
0.00% Others
A breakdown of David Bonita's holdings
See the Top Stocks by Insiders

Insider Roles

Enliven Therapeutics
(ELVN)
Director, Ten Percent Owner
Prelude Therapeutics
(PRLD)
Director, Ten Percent Owner
ImageneBio
(IMA)
Director
Acutus Medical
(AFIB)
Director
+1 other positions
Roles that David Bonita holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Viewray
(VRAYQ)
Rating:Informative Buy
Date:Jan 20, 2017 - Jan 20, 2018
Return:+110.20%
The most profitable trade made by David Bonita
See the Latest Stocks Traded by Insiders

David Bonita's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
LOXO
Loxo Oncology
Dec 12, 2017
―
Informative Sell
20.63M
$220.82M
VRAYQ
Viewray
Apr 25, 2018
Director, Ten Percent Owner
Uninformative Buy
―
―
TCDAQ
Tricida
Nov 25, 2022
―
Informative Sell
2.21M
$0.00
ELVN
Enliven Therapeutics
Jul 16, 2021
Director, Ten Percent Owner
Informative Buy
10.00M
$173.13M
RPTX
Repare Therapeutics
Sep 08, 2021
―
Uninformative Sell
274.79K
$254.90K
AFIB
Acutus Medical
Jun 15, 2023
Director
Uninformative Buy
―
$208.22
PRLD
Prelude Therapeutics
Apr 23, 2026
Director, Ten Percent Owner
Informative Buy
12.50M
$8.64M
IMA
ImageneBio
Jul 30, 2025
Director
Uninformative Buy
541.97
$4.66M
THRD
Third Harmonic Bio, Inc.
Sep 21, 2022
―
Uninformative Buy
―
$31.09M
~AMBI
Ambit
May 24, 2013
―
Informative Buy
233.37K
―
List of latest transactions for each holding click on a transaction to see David Bonita's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

David Bonita insider profile FAQ

What is the percentage of profitable transactions made by David Bonita?
The percentage of profitable transactions made by David Bonita is 43%.
    What is the average return per transaction made by David Bonita?
    The average return per transaction made by David Bonita is -19.20%.
      What stocks does David Bonita hold?
      David Bonita holds: LOXO, VRAYQ, TCDAQ, ELVN, RPTX, AFIB, PRLD, IMA, THRD, ~AMBI stocks.
        What was David Bonita’s latest transaction?
        David Bonita latest transaction was an Informative Buy of $12.50M.
          What was David Bonita's most profitable transaction?
          David Bonita’s most profitable transaction was an Informative Buy of VRAYQ stock on January 20, 2017. The return on the trade was 110.20%.
            What is David Bonita's role in Loxo Oncology?
            David Bonita's role in Loxo Oncology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.